Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication.
Ang D, Koo SH, Chan YH, Tan TY, Soon GH, Tan CK, Lin KW, Krishnasamy-Balasubramanian JK, Wong YJ, Kumar R, R R, Tan Y, Ong PJ, Tan YJ, Li JW, Kwek AB, Ang TL. Ang D, et al. Among authors: koo sh. Aliment Pharmacol Ther. 2022 Aug;56(3):436-449. doi: 10.1111/apt.17070. Epub 2022 Jun 3. Aliment Pharmacol Ther. 2022. PMID: 35665947 Clinical Trial.
Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers.
Koo SH, Soon GH, Pruvost A, Benech H, Ang TL, Lee EJD, Ang DSW. Koo SH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2022 Jul;395(7):815-826. doi: 10.1007/s00210-022-02235-1. Epub 2022 Apr 8. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35394133 Clinical Trial.
269 results